Dengue: a continuing global threat.

Guzman, MG; Halstead, SB; Artsob, H; Buchy, P; Farrar, J; Gubler, DJ; Hunsperger, E; Kroeger, A; Margolis, HS; Martínez, E; Nathan, MB; Pelegrino, JL; Simmons, C; Yoksan, S; Peeling, RW; (2010) Dengue: a continuing global threat. Nature reviews Microbiology, 8 (12 Suppl). S7-S16. ISSN 1740-1526 DOI:

Text - Accepted Version
License: Copyright the publishers

Download (1MB) | Preview


Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ?50 million dengue infections and ?500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
Research Centre: Vaccine Centre
PubMed ID: 21079655
Web of Science ID: 284748800003


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item